Drug- and chemical-induced cholestasis (Q34210563)

31 July 2017

1 reference

title

Drug- and chemical-induced cholestasis. (English)

1 reference

31 July 2017

Lewis JH

1

1 reference

31 July 2017

Zimmerman HJ

series ordinal

2

1 reference

31 July 2017

publication date

1 August 1999

1 reference

31 July 2017

published in

Clinics in liver disease

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

433-64, vii

1 reference

ORAL CONTRACEPTIVES AND LIVER DAMAGE.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Androgens in men--uses and abuses

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Dextropropoxyphene induced hepatotoxicity mimicking biliary tract disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Occupational hepatitis caused by methylenedianiline.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Liver reactions to oral low-dose tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Inhibitory Effects of Scillaren and Dinitrophenol on Bilirubin Excretion by the Isolated Perfused Rat Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Does long-term home parenteral nutrition in adult patients cause chronic liver disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

TWO CASES OF UNTOWARD REACTION AFTER "ILOSONE".

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Studies on bile secretion with the aid of the isolated perfused rat liver. I. Inhibitory action of sporidesmin and icterogenin.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Effect of rifampicin on liver function in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Fatality due to paraquat intoxication: confirmation by postmortem tissue analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

1 reference

7 January 2021

Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Vanishing bile duct syndrome in drug-induced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Oxacillin-Induced Hepatic Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Phalloidin-induced cholestasis: a microfilament-mediated change in junctional complex permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatic Toxicity Associated with Gold Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Autoantibodies against a kidney--liver protein associated with quinolone-induced acute interstitial nephritis or hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Fulminant hepatic failure associated with intravenous erythromycin lactobionate

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatic injury associated with nitrofurantoin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatocellular cholestasis: pathobiology and histological outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cholestatic hepatitis related to quinolones: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatoprotective properties of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

RECURRENT INTRAHEPATIC CHOLESTASIS OF PREGNANCY: OBSERVATIONS ON PATHOGENESIS

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Tetracycline-induced bile duct paucity and prolonged cholestasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatotoxic effects of the anabolic/androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

The biochemical studies on phalloidin-induced cholestasis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Effect of sodium taurolithocholate on bile flow and bile acid exeretion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Infusion of bile from methylene dianiline-treated rats into the common bile duct injures biliary epithelial cells of recipient rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Liver injury from cyclosporine A

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cyclosporin A hepatotoxicity in 66 renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Prolonged cholestasis due to trimethoprim sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cholestatic jaundice induced by ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Terbinafine-induced cholestatic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Acute cholangitis and pancreatitis associated with sulindac (clinoril).

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cimetidine cholestatic jaundice in children

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Prochlorperazine-induced chronic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Norfloxacin-Induced Cholestatic Jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Idiopathic adulthood ductopenia: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

An industrial outbreak of toxic hepatitis due to methylenedianiline

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hyperplasia of bile-ducts induced by alpha-naphthyl-iso-thiocyanate: experimental biliary cirrhosis free from biliary obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Propafenone-induced liver injury: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatic injury associated with paraquat toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

High incidence of poor sulfoxidation in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Pathophysiology of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

1 reference

7 January 2021

Hepatobiliary complications of total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Captopril-associated cholestatic jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Amoxicillin-clavulanate potassium-associated cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Terfenadine-induced cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Estrogen-Induced Cholestasis: Clues to Pathogenesis and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Hepatic injury in the toxic epidemic syndrome caused by ingestion of adulterated cooking oil (Spain, 1981)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cholestasis associated with mesalazine therapy in a patient with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Moxonidine-induced cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Chemical structure of erythromycin and hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Molecular pathogenesis of cholestasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

In vivo effects ofEscherichia coli endotoxin on sulfobromophthalein clearance in the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Fatal hepatotoxicity associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Severe penicillin-induced cholestasis in a 91-year-old woman

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Disappearing intrahepatic bile ducts: the syndromes and their mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Increased turnover of intrahepatic bile ducts induced by bromobenzene

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Intrahepatic Cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

Drug-induced cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970079-9

7 January 2021

10.1016/S1089-3261(05)70079-9

Identifiers

DOI

1 reference

release_wakdwmp6vnfvxhxc2xd7ckdc6q

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wakdwmp6vnfvxhxc2xd7ckdc6q

24 November 2022

mapped directly with Wikidata item

1 reference